Four Repetitive Partial Hydatidiform Moles Followed by Malignant Transformation to an Invasive Mole
Lian Zou,Xia Zhao,Zhengyu Li,Shengtao Zhou,Lin Zhou,Dan Su
DOI: https://doi.org/10.3109/00016349.2010.512072
2010-01-01
Acta Obstetricia Et Gynecologica Scandinavica
Abstract:Dear Sir, We wish to call attention to the case of a woman who had repeated partial hydatidiform mole 4 times followed by transformation to an invasive mole. The complete variety of hydatidiform moles is predominant while partial hydatidiform moles only account for 25 – 43% (1), and carry about a tenth of the risk of malignant transformation. The probability of repetitive hydatidiform moles increases from 1.3 to 21% with the maximum number of such occurrences reported being three (2). Only very few repetitive partial mole cases have been reported (3). A 41-year-old married nulliparous woman was admitted with 4 months of amenorrhea after an evacuation for the fourth partial hydatidiform mole. In 1997, 2007, 2008 and 2009, this patient had been admitted with similar complaints of amenorrhea and vaginal bleeding at 12, 9, 8 and 9 weeks of gestation, respectively, and partial molar pregnancies were pathologically verified in all cases. Color Doppler ultrasound examination now revealed a 5.2 × 5.6 × 5.1 cm3 mass in the muscular layer of the uterus 4 months after the last evacuation. Computed tomographic (CT) imaging of the chest showed bilateral pulmonary metastases and β-human chorionic gonadotropin (β-HCG) titer was 158,071 mIU/ml. Magnetic Resonance Imaging (MRI) screening of the brain showed no abnormalities. Stage III invasive mole was diagnosed. Combination chemotherapy regimens of 5-fluorouracil (5-Fu) and kengsengmycin (KSM) were given. Before the third chemotherapy course, serum β-HCG levels had fallen to normal, but the uterine mass persisted even though it had become smaller (Table 1). A total hysterectomy was performed for persistence of the uterine mass 1 month after the fourth course of chemotherapy. Pathologic examination revealed necrotic villi in the mass, without viable cytotrophoblast. In all pregnancies, she had conceived spontaneously with the same partner, a 45-year-old healthy man. Karyotypic analysis of the couple was normal. There was no familial history of repetitive hydatidiform mole pregnancies or consanguinity. During the post-surgical follow-up, no abnormal symptoms or signs were observed, and the HCG remained normal. The morbidity rates and precise etiology of partial moles are unknown. Risk factors may include nutrition, age and previous partial mole history. This woman had inferior food intake and tough natural circumstances, which along with age may have added to her risk. The risk may have been increased 10- to 20-fold because of the previous moles (4). The concept that a partial mole never transforms to malignant diseases is invalid. Several risk factors may increase the probability of transformation to an invasive mole, but Zalel et al. found that of 1893 patients with partial moles, malignancy after evacuation was seen in only 2.9% (5). Chemotherapy is the gold-standard therapy for invasive moles, but its role for treatment of partial moles is controversial. Repetitive partial moles are usually sporadic, though familial cases have also been reported in rare instances and may have a genetic basis with an autosomal recessive mutation (6).